ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Interventional Cardiology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,714Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 64

$1.01M Total Retail Price of All Prescriptions

Rank: 1 out of 64

1,010 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 11,433 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
ATORVASTATIN CALCIUM 1,515 1,206 10 1 8
CLOPIDOGREL 844 648 2 4
METOPROLOL TARTRATE 819 619 3 1
METOPROLOL SUCCINATE 764 553 4 10
AMLODIPINE BESYLATE 751 604 5 5
PLAVIX 637 504 6 9
SPIRONOLACTONE 608 520 7 19
CRESTOR 540 370 8 12
RANEXA 507 330 9 24
FUROSEMIDE 496 367 10 6
CARVEDILOL 426 340 11 2
NITROSTAT 419 339 12 21
FOSINOPRIL SODIUM 372 260 13 55
ATENOLOL 362 285 14 15
LISINOPRIL 335 241 15 7
POTASSIUM CHLORIDE 317 229 16 17
LIPITOR 296 207 17 31
PRAVASTATIN SODIUM 291 235 18 14
SIMVASTATIN 261 212 19 3
AMIODARONE HCL 224 189 20 28
DIGOXIN 196 186 21 18
BENAZEPRIL HCL 180 118 22 25
EFFIENT 172 90 23 20
ISOSORBIDE MONONITRATE ER 164 131 24 16
PRADAXA 163 132 25 26
LOSARTAN POTASSIUM 149 131 26 13
NITROGLYCERIN PATCH 148 128 27 29
HYDROCHLOROTHIAZIDE 136 90 28 22
SOTALOL 127 108 29 27
XARELTO 126 99 30 43
DIOVAN 126 108 30 34
WARFARIN SODIUM 115 107 32 11
LOVASTATIN 109 105 33 38
CHLORTHALIDONE 109 83 33 36
BUMETANIDE 108 87 35 46
KLOR-CON M20 103 102 36 54
QUINAPRIL HCL 98 84 37 66
ENALAPRIL MALEATE 98 81 37 40
DILTIAZEM 24HR CD 86 67 39 37
ISOSORBIDE DINITRATE 68 64 40 52
NIASPAN 64 44 41 33
TRIAMTERENE-HCTZ 55 43 42 45
LEVOTHYROXINE SODIUM 54 46 43 58
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 14, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.